"Results suggest that MC might be helpful for selected PD patients with insufficient symptom relief despite their usual anti-parkinsonian medication."
Region: Germany
The in vivo conversion of CBD to Δ9-THC is not supported by the majority of human or animal studies, investigators concluded.
At 20 months, the subject reported an improvement of compulsions and obsessions of more than 90 percent.
Consistent with the findings of other recent studies, authors reported. “[N]o conversion of CBD to THC was observed in any of the samples.”
Hannover, Germany: The use of cannabis and cannabinoids is associated with subjective benefits in patients…
Munich, Germany: The administration of cannabinoid-infused oils containing THC and CBD is associated with symptomatic…
Potsdam, Germany: The administration of oral THC (dronabinol) safely and effectively reduces pain in geriatric…
Düsseldorf, Germany: The presence of low levels of THC in blood is poorly correlated with…